Immaculada Margarit Y Ros

This inventor holds 19 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Immunogenic Compositions. Top assignees: Novartis Ag, Glaxosmithkline Biologicals Sa, Gsk Vaccines S.r.l.. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Immaculada Margarit Y Ros. Retrieved from https://idiyas.com/inventor/immaculada-margarit-y-ros

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 11)

% Patents Active = 68.4

CIPO Patents = 2 (Patent Applications = 8)

EPO Patents = 7 (Patent Applications = 21)

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 25(Granted Patents)

Company Filing History:

Glaxosmithkline Biologicals Sa

Novartis Vaccines & Diagnostics, Gmbh

patents

5. 1 out of 47

Novartis Vaccines and Diagnostics Srl

patents

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Immunogenic Compositions

Outer Membrane Vesicles

Carrier Molecule

Antigens

Polysaccharides

Streptolysin O

GAS57 Antigens

Nucleic Acids

Gram Positive Bacteria

Vaccines

Purification

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12653879 - OUTER MEMBRANE VESICLES (2026-06-16),

2. 11612664 - Immunogenic compositions (2023-03-28),

3. 10286055 - Immunogenic composition (2019-05-14),

4. 10245310 - Carrier molecule for antigens (2019-04-02),

5. 10150979 - Purification of secreted polysaccharides from S. agalactiae (2018-12-11),

6. 9855325 - Immunogenic composition (2018-01-02),

7. 9855324 - Immunogenic compositions (2018-01-02),

8. 9764027 - Outer membrane vesicles (2017-09-19),

9. 9102741 - GAS57 mutant antigens and GAS57 antibodies (2015-08-11),

10. 9102740 - Cna-B domain antigens in vaccines against gram positive bacteria (2015-08-11),

11. 8945589 - [object Object] (2015-02-03),

12. 8858957 - GAS57 mutant antigens and GAS57 antibodies (2014-10-14),

13. 8778358 - [object Object] (2014-07-15),

14. 8465751 - [object Object] (2013-06-18),

15. 8409589 - Mutant forms of streptolysin O (2013-04-02),

Title: Immaculada Margarit Y Ros: A Pioneer in Immunogenic Compositions

Introduction

Immaculada Margarit Y Ros is a distinguished inventor based in Siena, Italy. She has made significant contributions to the field of immunology, holding a total of 18 patents. Her work primarily focuses on developing immunogenic compositions that enhance immune responses in mammals.

Latest Patents

Among her latest patents, one notable invention is directed towards immunogenic compositions comprising conjugates of fragments from the capsular polysaccharide of Type III Group B Streptococcus (GBS). These fragments can be produced synthetically or through the depolymerization of native polysaccharides. Another significant patent involves methods for raising an immune response in mammals by administering an immunogenic composition that includes capsular saccharides from GBS serotypes conjugated to carrier proteins.

Career Highlights

Throughout her career, Immaculada has worked with prominent companies in the pharmaceutical industry, including Novartis AG and GlaxoSmithKline Biologicals SA. Her expertise and innovative approaches have positioned her as a key figure in the development of new immunological therapies.

Collaborations

Immaculada has collaborated with esteemed colleagues such as Guido Grandi and Domenico Maione, further enhancing her research and contributions to the field.

Conclusion

Immaculada Margarit Y Ros is a remarkable inventor whose work in immunogenic compositions has the potential to significantly impact public health. Her extensive patent portfolio and collaborations with leading companies and researchers underscore her importance in the field of immunology.

Profile summary based on public USPTO records.